Coronary Stents Market Size, Share & Industry Analysis
商品番号 : SMB-77946
| 出版社 | Fortune Business Insights |
| 出版年月 | 2025年5月 |
| ページ数 | 160 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,850 |
| 種別 | 英文調査報告書 |
北米は、確立された医療インフラ、高い医療費支出、そして心血管疾患に対する高い認知度に支えられ、冠動脈ステント市場をリードしています。欧州も僅差で追随し、アジア太平洋地域は予測期間中に最も高い成長率を達成すると予想されています。インドや中国などの新興国では、医療インフラの改善、保険適用範囲の拡大、そして認知度の高まりが成長の鍵となります。
Growth Factors of Coronary Stents Market
The global coronary stents market is poised for substantial growth, driven by the rising incidence of cardiovascular diseases (CVDs), advancements in medical technology, and expanding access to healthcare services. According to a comprehensive report by Fortune Business Insights, the market was valued at USD 6.68 billion in 2024 and is expected to reach USD 10.66 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.2% during the forecast period.
世界の冠動脈ステント市場は、心血管疾患（CVD）の発症率上昇、医療技術の進歩、そして医療サービスへのアクセス拡大を背景に、大幅な成長が見込まれています。Fortune Business Insightsの包括的なレポートによると、市場規模は2024年に66億8,000万米ドルと評価され、2032年には106億6,000万米ドルに達すると予測されており、予測期間中の年平均成長率（CAGR）は6.2%です。
What Are Coronary Stents?
Coronary stents are small mesh-like tubes inserted into narrowed or blocked coronary arteries during angioplasty procedures. Their primary function is to keep the artery open, ensuring adequate blood flow to the heart. Over the years, innovations in stent technology have significantly enhanced patient outcomes, reduced complications, and minimized repeat procedures.
Technological Advancements Fueling Growth
One of the most significant factors contributing to the market’s expansion is technological innovation. Modern coronary stents, particularly drug-eluting stents (DES), have revolutionized interventional cardiology by reducing the chances of restenosis—re-narrowing of the artery. These stents are coated with medication that helps prevent the growth of scar tissue, significantly improving long-term outcomes.
Furthermore, the development of bioresorbable stents—designed to gradually dissolve within the body after fulfilling their purpose—has garnered interest from both clinicians and patients. These devices reduce long-term complications associated with permanent implants, such as inflammation and blood clots.
Increasing Prevalence of Cardiovascular Diseases
Globally, cardiovascular diseases remain the leading cause of death, responsible for an estimated 17.9 million deaths annually. The increasing prevalence of sedentary lifestyles, unhealthy diets, smoking, and stress has further contributed to the rise in heart-related conditions. The growing burden of these diseases is directly driving the demand for effective and minimally invasive treatment options like coronary stenting.
Aging Population Boosting Demand
The aging population is another significant contributor to market growth. Older adults are more susceptible to coronary artery disease (CAD) due to age-related vascular changes and accumulated risk factors over time. With the global population aged 60 years and above expected to double by 2050, the demand for coronary stent procedures is likely to rise accordingly.
Market Segmentation Highlights
The coronary stents market is segmented based on stent type, deployment technique, end-user, and region.
- Stent Type: Drug-eluting stents dominate the market, accounting for the largest share due to their effectiveness in reducing complications post-surgery. Bioresorbable stents, though still emerging, show promising growth potential.
- Deployment Technique: Balloon-expandable stents are widely adopted for their precision, while self-expanding stents are used in tortuous vessels or cases requiring flexibility.
- End Users: Hospitals and ambulatory surgical centers represent the largest user base, driven by rising angioplasty procedures and access to specialized care.
Regional Insights
North America leads the coronary stents market, supported by a well-established healthcare infrastructure, high healthcare spending, and significant awareness of cardiovascular conditions. Europe follows closely, while Asia-Pacific is anticipated to witness the fastest growth rate during the forecast period. In emerging economies like India and China, improving healthcare infrastructure, increasing insurance coverage, and growing awareness are key growth drivers.
Competitive Landscape
Key players in the coronary stents market include:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic
- Terumo Corporation
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- MicroPort Scientific Corporation
These companies are heavily investing in research and development, strategic partnerships, and geographic expansion to strengthen their market presence and meet evolving patient needs.
________________________________________
Conclusion
With the combination of technological innovation, rising cardiovascular health concerns, and expanding access to healthcare services, the coronary stents market is expected to maintain a strong growth trajectory. As demand surges and research continues to advance, coronary stents will play an increasingly crucial role in managing cardiovascular diseases worldwide.
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2024
Forecast Period 2025-2032
Historical Period 2019-2023
Growth Rate CAGR of 6.2% from 2025-2032
Unit Value (USD Billion)
Segmentation
Stent Type, Material Type, Deployment, Application, End-user, and Region
By Stent Type
- Drug Eluting Stent
- Covered Stent
- Bare Metal Stent
- Bioresorbable Stent
- Others (Dual Therapy Stents)
By Material Type
- Metal
- Polymer
By Deployment
- Self-expandable
- Balloon-expandable
By Application
- Acute Coronary Syndrome (ACS)
- Chronic Coronary Syndrome (CCS)
By End-user
- Hospitals & ASCs
- Specialty Clinics
- Others
By Region
- North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)
o U.S.
o Canada
- Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
o Germany
o U.K.
o France
o Italy
o Spain
o Scandinavia
o Rest of Europe
- Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
o China
o Japan
o India
o Australia
o Southeast Asia
o Rest of Asia Pacific
- Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
o Brazil
o Mexico
o Rest of Latin America
- Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
o GCC
o South Africa
o Rest of Middle East & Africa
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Coronary Artery Disease (CAD), by Key countries/sub-region, 2023/2024
4.2. Technological Advancements in Coronary Stents
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
4.5. Impact of COVID-19 on the Market
5. Global Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Stent Type
5.1.1. Drug Eluting Stent
5.1.2. Covered Stent
5.1.3. Bare Metal Stent
5.1.4. Bioresorbable Stent
5.1.5. Others
5.2. Market Analysis, Insights and Forecast – By Material Type
5.2.1. Metal
5.2.2. Polymer
5.3. Market Analysis, Insights and Forecast – By Deployment
5.3.1. Self-expandable
5.3.2. Balloon-expandable
5.4. Market Analysis, Insights and Forecast – By Application
5.4.1. Acute Coronary Syndrome (ACS)
5.4.2. Chronic Coronary Syndrome (CCS)
5.5. Market Analysis, Insights and Forecast – By End-user
5.5.1. Hospitals & ASCs
5.5.2. Specialty Clinics
5.5.3. Others
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Stent Type
6.1.1. Drug Eluting Stent
6.1.2. Covered Stent
6.1.3. Bare Metal Stent
6.1.4. Bioresorbable Stent
6.1.5. Others
6.2. Market Analysis, Insights and Forecast – By Material Type
6.2.1. Metal
6.2.2. Polymer
6.3. Market Analysis, Insights and Forecast – By Deployment
6.3.1. Self-expandable
6.3.2. Balloon-expandable
6.4. Market Analysis, Insights and Forecast – By Application
6.4.1. Acute Coronary Syndrome (ACS)
6.4.2. Chronic Coronary Syndrome (CCS)
6.5. Market Analysis, Insights and Forecast – By End-user
6.5.1. Hospitals & ASCs
6.5.2. Specialty Clinics
6.5.3. Others
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1. U.S.
6.6.2. Canada
7. Europe Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Stent Type
7.1.1. Drug Eluting Stent
7.1.2. Covered Stent
7.1.3. Bare Metal Stent
7.1.4. Bioresorbable Stent
7.1.5. Others
7.2. Market Analysis, Insights and Forecast – By Material Type
7.2.1. Metal
7.2.2. Polymer
7.3. Market Analysis, Insights and Forecast – By Deployment
7.3.1. Self-expandable
7.3.2. Balloon-expandable
7.4. Market Analysis, Insights and Forecast – By Application
7.4.1. Acute Coronary Syndrome (ACS)
7.4.2. Chronic Coronary Syndrome (CCS)
7.5. Market Analysis, Insights and Forecast – By End-user
7.5.1. Hospitals & ASCs
7.5.2. Specialty Clinics
7.5.3. Others
7.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.6.1. Germany
7.6.2. U.K.
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Scandinavia
7.6.7. Rest of Europe
8. Asia Pacific Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Stent Type
8.1.1. Drug Eluting Stent
8.1.2. Covered Stent
8.1.3. Bare Metal Stent
8.1.4. Bioresorbable Stent
8.1.5. Others
8.2. Market Analysis, Insights and Forecast – By Material Type
8.2.1. Metal
8.2.2. Polymer
8.3. Market Analysis, Insights and Forecast – By Deployment
8.3.1. Self-expandable
8.3.2. Balloon-expandable
8.4. Market Analysis, Insights and Forecast – By Application
8.4.1. Acute Coronary Syndrome (ACS)
8.4.2. Chronic Coronary Syndrome (CCS)
8.5. Market Analysis, Insights and Forecast – By End-user
8.5.1. Hospitals & ASCs
8.5.2. Specialty Clinics
8.5.3. Others
8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. Australia
8.6.5. Southeast Asia
8.6.6. Rest of Asia Pacific
9. Latin America Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Stent Type
9.1.1. Drug Eluting Stent
9.1.2. Covered Stent
9.1.3. Bare Metal Stent
9.1.4. Bioresorbable Stent
9.1.5. Others
9.2. Market Analysis, Insights and Forecast – By Material Type
9.2.1. Metal
9.2.2. Polymer
9.3. Market Analysis, Insights and Forecast – By Deployment
9.3.1. Self-expandable
9.3.2. Balloon-expandable
9.4. Market Analysis, Insights and Forecast – By Application
9.4.1. Acute Coronary Syndrome (ACS)
9.4.2. Chronic Coronary Syndrome (CCS)
9.5. Market Analysis, Insights and Forecast – By End-user
9.5.1. Hospitals & ASCs
9.5.2. Specialty Clinics
9.5.3. Others
9.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.6.1. Brazil
9.6.2. Mexico
9.6.3. Rest of Latin America
10. Middle East & Africa Coronary Stents Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Stent Type
10.1.1. Drug Eluting Stent
10.1.2. Covered Stent
10.1.3. Bare Metal Stent
10.1.4. Bioresorbable Stent
10.1.5. Others
10.2. Market Analysis, Insights and Forecast – By Material Type
10.2.1. Metal
10.2.2. Polymer
10.3. Market Analysis, Insights and Forecast – By Deployment
10.3.1. Self-expandable
10.3.2. Balloon-expandable
10.4. Market Analysis, Insights and Forecast – By Application
10.4.1. Acute Coronary Syndrome (ACS)
10.4.2. Chronic Coronary Syndrome (CCS)
10.5. Market Analysis, Insights and Forecast – By End-user
10.5.1. Hospitals & ASCs
10.5.2. Specialty Clinics
10.5.3. Others
10.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.6.1. GCC
10.6.2. South Africa
10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2024)
11.2. Company Profiles (Overview, Products, Financials (based on availability), Recent Developments, Strategies, SWOT, Etc.)
11.2.1. Medtronic
11.2.2. Boston Scientific Corporation
11.2.3. BIOTRONIK SE & Co. KG
11.2.4. Terumo Corporation
11.2.5. Abbott
11.2.6. Relisys Medical Devices Limited.
11.2.7. B. Braun SE
11.2.8. MicroPort Scientific Corporation
11.2.9. Stentys S.A.
11.2.10. Meril Life Sciences Pvt. Ltd.
Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 提供ファイル：PDF（印刷不可）
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート